AbbVie Inc - Operating Expenses

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Expenses" stands at 32.46 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

AbbVie Inc's third quarter result of 7.50 Billion USD for the item "Operating Expenses" represents an increase of 4.71 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of 7.50 Billion USD for the item "Operating Expenses" represents an increase of 16.80 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 32.46 Billion USD for the item "Operating Expenses" represents an increase of 3.44 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 38.12 percent compared to the value the year prior.
The 1 year change in percent is 38.12.
The 3 year change in percent is 43.83.
The 5 year change in percent is 98.21.
The 10 year change in percent is 154.41.

The Serie's long term average value is 15.90 Billion United States Dollars. It's latest available value, on 09/30/2025, is 104.07 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 09/30/2025, is +311.55%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.